Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Judge

Showing results (191-200 of 260) with videos related to

Pageof 26
Sort By:
JACC. Clinical Electrophysiology|May 16, 2018
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With Adult-Onset DiseaseAnneline S J M Te Riele, Cynthia A James, Abhishek C Sawant, et al.
Journal of Cardiovascular Electrophysiology|May 1, 2018
Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)Brittney Murray, Edgar T Hoorntje, Anneline S J M Te Riele, et al.
Circulation. Genomic and Precision Medicine|April 8, 2021
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource FrameworkCynthia A James, Jan D H Jongbloed, Ray E Hershberger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 4, 2011
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Michael J Ackerman, Silvia G Priori, Stephan Willems, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
Elife|October 28, 2015
A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndromeJefferson J Doyle, Alexander J Doyle, Nicole K Wilson, et al.
Journal of Cardiac Failure|May 25, 2023
Impact of Donor Hemodynamics on Recipient Survival in Heart TransplantationSheng Fu, Chakradhari Inampudi, Bhavadharini Ramu, et al.
Heart Rhythm|July 27, 2011
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Michael J Ackerman, Silvia G Priori, Stephan Willems, et al.
Science (New York, N.Y.)|April 8, 2006
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndromeJennifer P Habashi, Daniel P Judge, Tammy M Holm, et al.
Heart (British Cardiac Society)|January 1, 2016
Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathyAnke R Hodes, Crystal Tichnell, Anneline S J M Te Riele, et al.
Pageof 26

Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
JACC. Clinical Electrophysiology|May 16, 2018
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With Adult-Onset DiseaseAnneline S J M Te Riele, Cynthia A James, Abhishek C Sawant, et al.
Journal of Cardiovascular Electrophysiology|May 1, 2018
Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)Brittney Murray, Edgar T Hoorntje, Anneline S J M Te Riele, et al.
Circulation. Genomic and Precision Medicine|April 8, 2021
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource FrameworkCynthia A James, Jan D H Jongbloed, Ray E Hershberger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 4, 2011
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Michael J Ackerman, Silvia G Priori, Stephan Willems, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
Elife|October 28, 2015
A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndromeJefferson J Doyle, Alexander J Doyle, Nicole K Wilson, et al.
Journal of Cardiac Failure|May 25, 2023
Impact of Donor Hemodynamics on Recipient Survival in Heart TransplantationSheng Fu, Chakradhari Inampudi, Bhavadharini Ramu, et al.
Heart Rhythm|July 27, 2011
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Michael J Ackerman, Silvia G Priori, Stephan Willems, et al.
Science (New York, N.Y.)|April 8, 2006
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndromeJennifer P Habashi, Daniel P Judge, Tammy M Holm, et al.
Heart (British Cardiac Society)|January 1, 2016
Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathyAnke R Hodes, Crystal Tichnell, Anneline S J M Te Riele, et al.
Pageof 26